Revive Therapeutics Stock Buy Hold or Sell Recommendation

RVVTF Stock  USD 0.02  0.0005  2.33%   
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Revive Therapeutics is 'Strong Hold'. Macroaxis provides Revive Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RVVTF positions. The advice algorithm takes into account all of Revive Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Revive Therapeutics' buy or sell advice are summarized below:
Real Value
0.0183
Hype Value
0.02
Market Value
0.022
Naive Value
0.0225
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Revive Therapeutics given historical horizon and risk tolerance towards Revive Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Revive Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Revive Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Revive and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Revive Therapeutics. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Execute Revive Therapeutics Buy or Sell Advice

The Revive recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Revive Therapeutics. Macroaxis does not own or have any residual interests in Revive Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Revive Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Revive TherapeuticsBuy Revive Therapeutics
Buy

Market Performance

Very WeakDetails

Volatility

Out of controlDetails

Hype Condition

Over hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Revive Therapeutics has a Risk Adjusted Performance of (0.02), Jensen Alpha of (0.44), Total Risk Alpha of (1.38) and Treynor Ratio of (0.30)
We provide trade recommendations to complement the recent expert consensus on Revive Therapeutics. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Revive Therapeutics is not overpriced, please check all Revive Therapeutics fundamentals, including its book value per share, as well as the relationship between the market capitalization and current liabilities . As Revive Therapeutics appears to be a penny stock we also advise to check out its price to earning numbers.

Revive Therapeutics Trading Alerts and Improvement Suggestions

Revive Therapeutics had very high historical volatility over the last 90 days
Revive Therapeutics has some characteristics of a very speculative penny stock
Net Loss for the year was (17.81 M) with profit before overhead, payroll, taxes, and interest of 0.
Revive Therapeutics has accumulated about 5.29 M in cash with (13.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.

Revive Therapeutics Returns Distribution Density

The distribution of Revive Therapeutics' historical returns is an attempt to chart the uncertainty of Revive Therapeutics' future price movements. The chart of the probability distribution of Revive Therapeutics daily returns describes the distribution of returns around its average expected value. We use Revive Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Revive Therapeutics returns is essential to provide solid investment advice for Revive Therapeutics.
Mean Return
-0.33
Value At Risk
-12.12
Potential Upside
14.29
Standard Deviation
7.58
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Revive Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Revive Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Revive Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Revive Therapeutics' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Revive otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.44
β
Beta against NYSE Composite1.15
σ
Overall volatility
7.43
Ir
Information ratio -0.06

Revive Therapeutics Volatility Alert

Revive Therapeutics is displaying above-average volatility over the selected time horizon. Revive Therapeutics is a penny stock. Although Revive Therapeutics may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Revive Therapeutics. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Revive instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Revive Therapeutics Fundamentals Vs Peers

Comparing Revive Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Revive Therapeutics' direct or indirect competition across all of the common fundamentals between Revive Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Revive Therapeutics or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Revive Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Revive Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Revive Therapeutics to competition
FundamentalsRevive TherapeuticsPeer Average
Return On Equity-0.83-0.31
Return On Asset-0.43-0.14
Current Valuation32.12 M16.62 B
Shares Outstanding353.56 M571.82 M
Shares Owned By Insiders2.48 %10.09 %
Shares Owned By Institutions2.42 %39.21 %
Price To Earning(4.10) X28.72 X
Price To Book4.00 X9.51 X
EBITDA(17.74 M)3.9 B
Net Income(17.81 M)570.98 M
Cash And Equivalents5.29 M2.7 B
Cash Per Share0.02 X5.01 X
Total Debt60 K5.32 B
Debt To Equity0.02 %48.70 %
Current Ratio1.83 X2.16 X
Book Value Per Share0.03 X1.93 K
Cash Flow From Operations(13.06 M)971.22 M
Earnings Per Share(0.06) X3.12 X
Number Of Employees1618.84 K
Beta-0.0535-0.15
Market Capitalization36.1 M19.03 B
Total Asset17.07 M29.47 B
Retained Earnings(4.38 M)9.33 B
Working Capital132 K1.48 B
Current Asset635 K9.34 B
Current Liabilities503 K7.9 B
Net Asset17.07 M

Revive Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Revive . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Revive Therapeutics Buy or Sell Advice

When is the right time to buy or sell Revive Therapeutics? Buying financial instruments such as Revive OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Revive Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Oil And Gas Thematic Idea Now

Oil And Gas
Oil And Gas Theme
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
View All  Next Launch
Check out Revive Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Revive OTC Stock analysis

When running Revive Therapeutics' price analysis, check to measure Revive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revive Therapeutics is operating at the current time. Most of Revive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Revive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revive Therapeutics' price. Additionally, you may evaluate how the addition of Revive Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Please note, there is a significant difference between Revive Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revive Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revive Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.